cellular-agriculture
(5)
Calysta
Calysta is a San Mateo, California biotechnology company that uses a patented gas-fermentation platform to turn methane into FeedKind, a single-cell protein for aquaculture, livestock and pet feed - and increasingly human food. Its bacteria eat natural gas instead of arable land, plants or animals, producing protein with a low environmental footprint. Backed by Cargill, BP and Temasek and partnered with Adisseo through the Calysseo joint venture, Calysta opened the world's first industrial-scale single-cell protein plant in Chongqing, China in 2022.
Foray Bioscience
Foray Bioscience is a Cambridge, Massachusetts biotech company growing plants and plant products from single cells. Founded in 2022 by MIT PhD Ashley Beckwith, Foray pairs plant cell culture with AI to make lab-grown plant material predictable across species - unlocking harvest-free wood and materials, rapidly scalable seed supplies, faster crop improvement, and even conservation and de-extinction work. Its Pando software acts like a 'Google Maps for plant growth,' helping researchers navigate the dozens of variables that govern how a plant cell grows.
TurtleTree
TurtleTree is a biotech and food-tech company that makes lactoferrin - one of the rarest and most valuable proteins in cow's milk - without the cow. Using precision fermentation, its flagship ingredient LF+ recreates the bioactive milk protein at scale for use in immunity, gut health, sports nutrition and infant nutrition products. In 2025 TurtleTree became the first company in the world to win an FDA 'No Questions' GRAS letter for precision-fermented lactoferrin, clearing it to commercialize in the U.S.
Fork & Good, Inc.
Fork & Good is a Jersey City-based cellular agriculture company growing real meat from animal cells instead of whole animals. Founded by urban-farming entrepreneur Niya Gupta and cultivated-meat pioneer Gabor Forgacs, the company built a pilot factory that produces cultivated pork using a patented bioprocess centered on muscle cells and high-density bioreactors. Its goal is to reach price parity with commodity meat - targeting roughly $2 per pound - while using a fraction of the land and water of conventional farming. In 2025 it acquired California's Orbillion Bio to combine cultivated pork and beef under one global platform spanning North America, Europe, Asia and the Middle East.
Wildtype
Wildtype is a San Francisco-based cultivated seafood company that grows real salmon from fish cells in stainless steel bioreactors - no fishing, no farming, no ocean required. Founded in 2016 by a cardiologist-turned-food-scientist and a former U.S. Foreign Service officer, the company received FDA clearance in May 2025, making it the first cultivated seafood product approved for sale in the United States. With $123.5M raised and backing from Jeff Bezos, Leonardo DiCaprio, and Cargill, Wildtype is betting that the future of seafood is grown, not caught.